Author:
Taylor Reggie,Neufeld Richard W J,Schaefer Betsy,Densmore Maria,Rajakumar Nagalingam,Osuch Elizabeth A,Williamson Peter C,Théberge Jean
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference63 articles.
1. Gruber O, Santuccione AC, Aach H . Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system. Front Psychiatry 2014; 5: 1–11.
2. Javitt DC, Zukin SR . Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991; 148: 1301–1308.
3. Coyle JT, Tsai G . The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berl) 2004; 174: 32–38.
4. Tamminga CA, Holcomb HH, Gao XM, Lahti AC . Glutamate pharmacology and the treatment of schizophrenia: current status and future directions. Int Clin Psychopharmacol 1995; 10 (Suppl 3): 29–37.
5. Gilbert-Rahola J, Villena-Rodriguez A . Glutamatergic drugs for schizophrenia treatment. Actas Esp Psiquiatr 2014; 42: 234–241.
Cited by
71 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献